NORTH WEST LUNG CENTRE

Registered charity 1090320 · accounts filings on the Charity Commission register

Promoting and assisting with the funding of research into lung disease in the North West of England

Causes: The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · Get email alerts

Latest income
£20.9m
Latest spending
£16.0m
Registered
2002
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the group's unrestricted reserves increased significantly to £129,919,251 following a £90.1 million gain on the revaluation of subsidiary shares. The trustees report that the continuous success and profitability of the subsidiary companies allows the charity to maintain unrestricted reserves at a level that can be re-assessed annually. The group generated a net incoming resource of £94.8 million, driven largely by investment gains rather than operational surplus.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: sufficient reserves to enable the Charity to continue to support current research (held: £129.9m)
“It is the trustee’s policy to maintain sufficient reserves to enable the Charity to continue to support current research.” — page 7
Per its FY2025 accounts as filed with the Charity Commission.
Payments to trustees: An honorarium of £6,000 was payable to trustee J Alcock in the year.
“An honorarium of £6,000 was payable to trustee J Alcock in the year (2024 £Nil).” — page 27
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Dividends paid to directors of subsidiaries
“During the year, total dividends of £1,147,791 (2024 - £495,788) were paid to the directors of Medicines Evaluation Unit Limited and CRO Solutions Limited.” — page 36
“Professional fees of £nil (2024 - £7,236) were paid to Eversley Resolutions, a business operated by Mr J Alcock, a trustee of the charitable company.” — page 36
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Professional fees to trustee-connected business
“During the year, total dividends of £1,147,791 (2024 - £495,788) were paid to the directors of Medicines Evaluation Unit Limited and CRO Solutions Limited.” — page 36
“Professional fees of £nil (2024 - £7,236) were paid to Eversley Resolutions, a business operated by Mr J Alcock, a trustee of the charitable company.” — page 36
Per its FY2025 accounts as filed with the Charity Commission.
Trading subsidiary: Medicines Evaluation Unit Limited, CRO Solutions Limited
“The Charity owned 84.92% of the share capital of Medicines Evaluation Unit Limited and 69.87% of the share capital of CRO Solutions Limited. Medicines Evaluation Unit Limited is a company principally engaged in evaluating medicines for the pharmaceuticals industry. CRO Solutions Limited is a clinical research organisation.” — page 8
Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by Mitchell Charlesworth (Audit) Limited. Discloses 3 of 6 completeness components.

Corporate structure

MEDICINES EVALUATION UNIT LIMITED — per its own Companies House accounts
  • Turnover: £18.2m
  • Profit before tax: £6.0m
CRO SOLUTIONS LIMITED — per its own Companies House accounts
  • Turnover: £7.2m
  • Profit before tax: £512k
  • Sales of £795,719 and purchases of £4,964,812 with Medicines Evaluation Unit Limited.

Public fundraising profile: JustGiving — North West Lung Centre Charity Ltd (matched by registered charity number).

Company officers (Companies House)

Current officers of the charity’s own company per the Companies House register, cross-checked against the Charity Commission trustee list by name. A director not on the trustee list is usually a timing or naming difference between the two registers — check both records before drawing conclusions.

Official officers record.

Property (HM Land Registry)

2 registered titles in England and Wales held by the charity’s company or corporate body (0 freehold); recorded price paid £460k. All charity-held property. Contains HM Land Registry data © Crown copyright, OGL v3.0.

Structured financials (annual return, FY ending 31/03/2025)

Total income
£20.9m
Total spending
£16.0m
Cost of raising funds
£11k
Reserves (reported)
£129.9m
Employees
175

Reported reserves equal ~97.3 months of spending — in the top quarter for charities its size (median 4.6 months; benchmarks).

Per its annual return, largest income source: Other trading activities (94% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 0.1% of total income — below the median for charities its size (3.8%) (benchmarks).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England

Income and spending

Financial year endIncomeSpending
31/03/2025£20.9m£16.0m
31/03/2024£19.6m£13.0m
31/03/2023£19.0m£15.1m
31/03/2022£17.5m£13.1m
31/03/2021£15.9m£12.5m

Common questions

Is NORTH WEST LUNG CENTRE financially healthy?

Per its FY2025 accounts: The accounts state that the group's unrestricted reserves increased significantly to £129,919,251 following a £90.1 million gain on the revaluation of subsidiary shares. The trustees report that the continuous success and profitability of the subsidiary companies allows the charity to maintain unrestricted reserves at a level that can be re-assessed annually. The group generated a net incoming resource of £94.8 million, driven largely by investment gains rather than operational surplus. Its FY2025 accounts were audited by Mitchell Charlesworth (Audit) Limited.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR).

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
NORTH WEST LUNG CENTRE£20.9m——above—no doubt
NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR) FY2025£2.3m——above—no doubt
Asthma and Lung UK FY2025£16.1m——unclear—no doubt
LONDON NORTH WEST HEALTHCARE CHARITABLE FUND FY2025£769k—3above—no doubt
EUROPEAN LUNG FOUNDATION FY2025£498k——unclear—no doubt
BOURNEMOUTH AND POOLE HEALTHCARE TRUST (1) FY2025£4.4m—0unclear—not going concern

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.